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Blood Transfusion Practices in Total Joint Arthroplasties 
in Jamaica
RE Christopher Rosea, c, Ayana Crichlowa, Christine Waltersb, Andrew Ameerallya, 
Georgiana Gordon-Strachana
Abstract
Background: Major blood loss usually occurs in both hip and knee 
arthroplasty, frequently leading to the need for blood transfusion. 
This study was performed to determine blood transfusion rates and 
analyze the factors which affected the need for blood transfusion 
in patients who underwent primary unilateral total knee and hip ar-
throplasties at the University Hospital of the West Indies, Jamaica.
Methods: A prospective study of 118 patients who underwent uni-
lateral total knee and total hip arthroplasties between January 2004 
and July 2009 was undertaken. Data collected was analyzed using 
Microsoft Excel 2008, SPSS version 12 and Stata version 7.0.
Results:  Of the 118 patients, 90 (70%) were females. Mean ± 
standard deviation (SD) age was 65.2 ± 11.5 years (range 32 – 85 
years). Osteoarthritis accounted for the majority (88%) of arthro-
plasties. Mean ± SD estimated blood loss for all arthroplasties was 
1195.0 ± 855.6 ml (range 100 – 6000 ml). Mean ± SD duration 
of surgery for all joint arthroplasties was 226.1 ± 63.5 minutes 
(range 110 – 392 minutes). Mean ± SD preoperative hemoglobin 
was 12.09 g/dl (range 7.3 – 15.6 g/dl). Average body mass index 
was 28.9 kg/m2  (range 17.9 – 68.3 kg/m2). Seventy-five (64%) 
patients were transfused and of these, 44 patients received allogenic 
blood only; 20 patients received autologous blood only, and eleven 
patients received both allogenic and autologous blood.  The overall 
blood transfusion rate was 63%.
Conclusions:  In our study, the multivariate analysis showed a sig-
nificant relationship (p = 0.000) only between postoperative trans-
fusion and the estimated blood loss.
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Introduction
Total knee and hip arthroplasties are usually associated with 
significant blood loss and many patients require periopera-
tive transfusion [1, 2]. The reported mean estimated blood 
loss is between 495 and 1,493ml per procedure [3-5]. Al-
logenic transfusion is associated with a number of problems, 
including the risk of transmission of infectious diseases such 
as Human Immunodeficiency Virus and hepatitis, as well as 
transfusion-related and allergic reactions [6-8]. In addition, 
some patients refuse a blood transfusion because of religious 
beliefs. In order to minimize the disadvantages of allogenic 
transfusions, alternatives such as preoperative haemodilu-
tion, anesthetic hypotension, intraoperative and postopera-
tive blood recovery, preoperative donation of blood, and hu-
man recombinant erythropoietin, are currently being used 
[9-11].
The  aim  of  this  prospective  study  was  to  determine 
blood transfusion rates and analyze the factors which affect-
ed the need for blood transfusion in patients who underwent 
primary unilateral total knee and hip arthroplasties at the 
University Hospital of West Indies, Jamaica.
 
Patients and Methods
Between January 2004 and July 2009, 148 consecutive pa-
tients who underwent total knee and total hip arthroplasties 
by three orthopaedic surgeons at the University Hospital of 
the West Indies in Jamaica were prospectively studied. Pa-
tients were excluded from the study if they were undergoing 
total joint arthroplasty for a hip fracture; were undergoing 
revision surgery; had a haematological disease; were being 
treated with warfarin for anticoagulation; had liver impair-
ment; had had gastro-intestinal bleeding; were undergoing 
simultaneous joint arthroplasties or received a transfusion 
in the preoperative period. There were seven bilateral total 
joint arthroplasties; 19 revisions; two patients with liver im-
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pairment, and two patients with a history of gastro-intestinal 
bleeding. The study population consisted of 118 unilateral 
primary total joint arthroplasties. There were ten patients 
each of whom underwent two procedures during the study. 
Informed consent was obtained from all of the patients. Of 
the ten patients, five patients each had two primary total knee 
arthroplasties; three patients each had two primary total hip 
arthroplasties, and two patients each had a primary total hip 
and primary total knee arthroplasty. The range of time be-
tween the procedures was seven days to 69 months.  The fol-
lowing information was recorded for each patient; diagnosis, 
procedure, age, gender, body mass index (BMI), duration 
of surgery, preoperative hemoglobin, estimated blood loss, 
type of anesthesia, number of predonated autologous units of 
blood, number of patients transfused and the number of units 
of blood discarded.  
Data  collected  was  analyzed  using  Microsoft  Excel 
2008, SPSS version 12 and Stata version 7.0. Descriptive 
statistics were generated as appropriate. Student t-tests were 
used to compare average values for continuous variables. 
Logistic regression models were also used to examine which 
variables were predictive of the risk for post-surgery transfu-
sion.  Statistical significance for all tests was set at 5%.
 
Results
Of the 118 patients, 90 (76%) were females. The mean ± 
standard deviation (SD) age was 65.2 ± 11.5 years (range 
32 – 85 years). One hundred and eighteen total joint arthro-
plasties were performed of which 63 were total knees and 55 
were total hips. The gender distribution of the joint arthro-
plasties was 51 (81%) females in the total knee arthroplasty 
group, and 39 (71%) females in the total hip arthroplasty 
group. The diagnosis of the patients who underwent total 
knee and hip arthroplasties were as follows:  osteoarthritis 
accounted  for  104  arthroplasties;  rheumatoid  arthritis  for 
nine arthroplasties; systemic lupus erythematosis for three 
arthroplasties and avascular necrosis for seven arthroplas-
ties.  Five  patients  had  more  than  one  diagnosis. Average 
body mass index (or BMI) for the 104 patients with avail-
able information was 28.9 kilograms per meters squared (kg/
m2), ranging from17.9 to 68.3 kg/m2. The mean ± SD dura-
tion of surgery for all joint arthroplasties was 226.1 ± 63.5 
minutes (range 110 - 392 minutes). The mean ± SD duration 
of surgery for total knee arthroplasties was 225.9 ± 66.2 min-
utes (range 115 -392 minutes). The mean ± SD duration of 
surgery for total hip arthroplasties was 226.4 ± 60.9 minutes 
(range 110 - 360 minutes).
The mean ± SD estimated blood loss for all arthroplas-
ties was 1195.0 ± 855.6 ml (range 100 – 6000 ml). The mean 
blood loss in total knee arthroplasties was 1,106.2 ± 645.1 
ml (range 100 - 3,200 ml). The mean blood loss in total hip 
arthroplasties was 1,295.1 ± 1,040.8 ml (range 200 – 6000 
ml). One patient who underwent a total hip arthroplasty had 
an estimated blood loss of 6 liters. The types of anesthesia 
utilized were 43 general anesthesia, 57 regional anesthesia, 
and 18 combined regional and general anesthesia.
The mean ± SD preoperative hemoglobin was 12.0 ± 
1.4 g/dl (range 7.3 - 15.6 g/dl).  Seventy-five (64%) patients 
were transfused and of these patients 44 patients received 
allogenic blood only; 20 patients were transfused autologous 
blood only and eleven patients received both allogenic and 
autologous blood. Thirty-six (30%) patients predonated a to-
tal of 46 units of blood. Of the 75 patients who were trans-
fused, 33 (44%) donated autologous blood. A total of 144 
Figure 1. Blood transfusion requirements. THA (total hip arthroplasty), TKA (total knee arthroplasty).
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units of blood were transfused with 101 units being allogenic 
transfusions. The number of units transfused was higher for 
the total knee arthroplasty group (81 units), than for the total 
hip arthroplasty group (63 units) (Fig. 1).
The overall blood transfusion rate was 63% (total knee 
arthroplasty 67%; total hip arthroplasty 60%).  Number of 
units transfused per procedure was approximately 2:1.
A total of 6 units of blood were unused (3 units of autolo-
gous blood and 3 units of allogenic blood). Table 1 shows the 
results of multivariable logistic regression to assess whether 
preoperative hemoglobin levels, age, gender, BMI, duration 
of surgery, estimated blood loss, and type of anesthesia were 
predictive of risk for post-surgery transfusion.
Predicted  risk  of  post-surgery  transfusion,  generated 
based on the logistic regression model in Table 1, were plot-
ted against preoperative hemoglobin levels (Fig. 2). A fitted 
linear regression line was super-imposed, showing a direct 
relationship between predicted risk of post-surgery transfu-
sion and preoperative hemoglobin levels after adjusting for 
gender, age, BMI, duration of surgery, estimated blood loss, 
Variable Odds Ratio 95% CI P-value
Gender (M vs F)
Age
Pre-op Hb
BMI
Duration of surgery
Est. blood loss
Type of anesthesia
     Regional vs General
     Combined vs General
0.544
1.005
1.289
1.046
1.005
1.002
2.033
1.026
0.153 - 1.936
0.960 - 1.053
0.865 - 1.921
0.932 - 1.174
0.995 - 1.015
1.001 - 1.003
0.620 - 6.668
0.220 – 4.785
0.347
0.815
0.212
0.447
0.354
0.000*
0.242
0.974
Table 1.  Logistic Regression Analysis to Assess Factors Impacting the Risk of Post-surgery 
Transfusion
N = 102, patients with non-missing values.
Figure 2. Graphing the predicted risk of post-surgery transfusion against preoperative hemoglobin values (adjusted for 
all the other variables listed in Table 1).
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and type of anesthesia.
Thirty-six patients donated blood, and 33 of these pa-
tients were transfused with autologous blood post-surgery. 
Table  2  summarizes  the  multivariable  logistic  regression 
when the 36 patients who donated blood were excluded.
As done previously, predicted risk of post-surgery trans-
fusion, generated based on the logistic regression model in 
Table 2, were plotted against preoperative hemoglobin levels 
(Fig. 3). The fitted linear regression line showed an inverse 
relationship between predicted risk of post-surgery transfu-
sion and preoperative hemoglobin levels after adjusting for 
gender, age, BMI, duration of surgery, estimated blood loss, 
and type of anesthesia.
Based on t-tests for the comparison of means, average 
preoperative hemoglobin values did not differ significantly 
between persons who were or were not transfused post-sur-
gery. That finding was consistent within gender as well as 
when persons who donated autologous blood were excluded. 
Among males who did not donate autologous blood and then 
were later transfused, their mean preoperative hemoglobin 
Figure 3. Graphing the predicted risk of post-surgery transfusion against preoperative hemoglobin  values (ad-
justed for all the other variables listed above where patients who donated autologous blood are excluded).
Variable Odds Ratio 95% CI P Value
Gender (M vs F)
Age
Pre-op Hb
BMI
Duration of surgery
Est. blood loss
Type of anesthesia
     Regional vs General
     Combined vs General
0.277
1.015
0.777
1.107
1.007
1.002
2.568
1.474
0.032 – 2.393
0.951 - 1.084
0.413 - 1.463
0.954 - 1.286
0.993 - 1.022
1.001 - 1.004
0.554 - 11.889
0.042 - 5.285
0.243
0.651
0.435
0.181
0.329
0.002*
0.228
0.544
Table 2. Logistic Regression Analysis to Assess Factors Impacting the Risk of Post-surgery Transfusion
N = 68 patients with non-missing values and who did not donate blood.
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was 12.0 g/dl, compared to 11.6 g/dl among their female 
counterparts (P-value = 0.575, not significant). Males who 
did not donate autologous blood and were never transfused 
had an average preoperative hemoglobin of 13.1 g/dl com-
pared to 11.5 g/dl for their female counterparts (P < 0.001, 
significant) (Tables 3, 4).
Discussion
  
A patient’s risk of requiring a transfusion during surgery and 
in the immediate postoperative period is an important ele-
ment of effective blood management. Estimated periopera-
tive blood loss and preoperative hemoglobin concentration 
are critical predictors of the need for blood transfusion. In 
our study, the multivariate analysis showed a significant rela-
tionship only between postoperative transfusion and the es-
timated blood loss (p = 0.000). Table 1 revealed that persons 
were 28.9% more likely to need post-surgery transfusion 
given a 1g/dl increase in preoperative hemoglobin levels.   
However, this value was non-significant (95% confidence 
interval (CI) for the odds ratio: 0.865 – 1.921, p = 0.212).   
From Table 2, although the odds ratio for preoperative he-
moglobin levels remained non-significant (95% CI: 0.413 – 
Was patient 
transfused?
Number of 
patients
Pre-operative Hemoglobin
Mean
Standard 
Deviation
95% CI P-value
All Patients:
        No 43 11.9 1.3 11.5 – 12.3
0.359
       Yes 75 12.1 1.4 11.8 – 12.4
Females only
       No 32 11.5 1.0 11.1 – 11.9
0.094
       Yes 58 11.9 1.3 11.6 – 12.3
Males only
       No 11 13.0 1.2 12.2 – 13.9
0.555
      Yes 17 12.7 1.5 11.9 – 13.5
Table 3. Analysis of Average Preoperative Hemoglobin Levels in all Patients
Was patient 
transfused?
Number of 
patients
Pre-operative Hemoglobin
Mean
Standard 
Deviation
95% CI P-value
All Patients:
        No 40 11.9 1.3 11.5 – 12.3
0.462
       Yes 42 11.7 1.3 11.2 – 12.1
Females only
       No 31 11.5 1.0 11.1 – 11.9
0.730
       Yes 37 11.6 1.3 11.2 – 12.1
Males only
       No 9 13.1 1.4 12.1 – 14.2
0.154
      Yes 5 12.0 1.3 10.3 – 13.6
Table 4. Analysis of Average Preoperative Hemoglobin Levels in Persons who did not Donate Blood
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1.463; p = 0.435), there is a reversal in the direction of its 
impact on the risk for post-surgery transfusion. Persons were 
now 22.3% less likely to need post-surgery transfusion giv-
en a 1g/dl increase in preoperative hemoglobin levels, after 
adjusting for gender, age, BMI, surgery duration, estimated 
blood loss during surgery and type of anesthesia used. These 
results are not consistent with the findings in the literature. 
Several studies have established a relationship between the 
preoperative hemoglobin level and the need for postopera-
tive blood transfusion [3-5, 12]. The abnormal finding in our 
study can possibly be explained by the absence of hemoglo-
bin levels immediately preoperative in some of the patients 
who  predonated  blood.  These  patients,  after  predonation, 
possibly had low preoperative hemoglobin levels. Thirty-
three of 36 patients who predonated blood were transfused 
their autologous blood post-surgery. The results would be 
skewed  since  the  analysis  was  performed  using  predona-
tion hemoglobin levels rather than immediate preoperative 
hemoglobin levels in some of the patients who predonated 
blood. The multivariable analysis with the exclusion of the 
36 patients who donated blood revealed that the preoperative 
hemoglobin levels remained non-significant but there was a 
reversal in the direction of its impact on the need for post-
surgery transfusion.
Salido et al [12] reported that patients with a preop-
erative hemoglobin level less that 13 g/dl had a four times 
greater risk of having a transfusion than did those with a he-
moglobin level between 13 g/dl and 15 g/dl, and a 15.3 times 
greater risk than did those with a hemoglobin level of greater 
than 15 g/dl. Bierbaum et al [3] also reported that the rate of 
breakthrough transfusion was highest for their patients who 
had a baseline hemoglobin that was between 10 g/dl and 13 
g/dl.
Salido et al [12] and Bierbaum et al [3] found that the 
prevalence of blood transfusion after hip surgery was higher 
than that after knee surgery, although this difference was 
not significant. In our study, the blood transfusion rate was 
higher in knee surgery (67%) than hip surgery (60%). The 
average blood transfusion rates for total knee and hip arthro-
plasties in studies by Bierbaum et al [3], Feagan et al [13], 
and Pierson et al [4] were 49%, 27% and 2.1% respectively. 
Our transfusion rate was 63%. There was no standard proto-
col for proceeding with a transfusion in our study. Instead, 
the decision for blood transfusion was based on the patient’s 
overall clinical status and co-morbidities.  Many authors ad-
vocate that postoperative transfusion trigger can be brought 
to 8 g/dl in a haemodynamically stable patient [5, 14, 15].
Bierbaum et al [3] confirmed in their study that allogenic 
blood was transfused despite extensive use of predonated au-
tologous blood. Twenty percent (796) of the 3,920 patients 
who had a procedure on the hip and 13% (723) of the 5,552 
who had a procedure on the knee had a transfusion of al-
logenic blood. The rates of transfusion of allogenic blood 
were highest for the patients who had a revision or a bilateral 
procedure and for those who had a baseline hemoglobin level 
of 13 g/dl or less. In our study, of the 75 patients who were 
transfused, 44 (59%) received allogenic blood.  A total of 
144 units of blood were transfused with 101 units being al-
logenic transfusions.
The use of preoperative autologous blood donation has 
increased substantially although it has been associated with 
such  risks  as  preoperative  anaemia,  ischemic  events,  and 
complications severe enough to require hospitalization [16, 
17]. Furthermore, the magnitude and rate of patient response 
to compensatory erythropoiesis to replace donated red blood 
cells generally has been overestimated [18]. In one study 
[19], preoperative donation between 42 and seven days be-
fore surgery still resulted in an average decrease of 1g/dl for 
every unit of autologous blood donated, suggesting an ab-
sence of adequate compensatory erythropoiesis. Over collec-
tion of blood is also a problem associated with preoperative 
autologous donation. As much as 50% of autologous blood is 
unused in patients undergoing joint replacement [18]. Bier-
baum et al [3] found that a high percentage of autologous 
blood was discarded, and many patients never received any 
of there predonated units. In our study, 36 (30%) of 118 pa-
tients predonated a total of 46 units of blood. Three units 
of autologous blood were unused. Two units were donated 
by one patient who had tested positive for HIV. One patient 
refused autologous transfusion.
A major weakness of this study is the small study popu-
lation. The University Hospital of the West Indies is a low 
volume centre for total hip and knee arthroplasties.  The high 
trauma burden on our operating lists, the limited operating 
time and the great consumption of blood by trauma patients 
are the main reasons for the small numbers in this paper. Our 
results have shown that there is no relationship between age, 
gender, BMI, duration of surgery, type of anesthesia and pre-
operative hemoglobin level and the need for postoperative 
blood transfusion. There was a significant relationship be-
tween the estimated blood loss and the need for postopera-
tive blood transfusion.
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